Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.420
-0.070 (-4.70%)
At close: Nov 13, 2026, 4:00 PM EST
1.460
+0.040 (2.82%)
After-hours: Nov 13, 2026, 5:14 PM EST
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $4.68 million as of November 13, 2026. Its market cap has decreased by 70.44% in one year.
Market Cap
4.68M
Enterprise Value
-1.84M
1-Year Change
-70.44%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $4.68M, a decrease of -74.67%. That is a compound annual growth rate of -7.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.88M | -80.19% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 5.42M |
| Skye Bioscience | 5.22M |
| Acurx Pharmaceuticals | 5.03M |
| Niki BioSolutions | 4.87M |
| Pulmatrix | 4.66M |
| Senti Biosciences Holdings | 4.53M |
| AIM ImmunoTech | 4.38M |
| CNS Pharmaceuticals | 4.33M |